By Ed Miseta, Chief Editor, Outsourced Pharma and Clinical Leader
From the time she was young, Kristin Rand's mother said she would be an actress or a lawyer. Although she thought her mother was probably correct, she didn't like the prospect of becoming either, merely because she did not want her mother to have predicted her future. While in high school she developed an interest in genetics, and the promise it held for the future of personalized medicine. Rand notes she always had an interest in the questions that science had not yet answered.
By Dr. Andrea Eckhart, Metabolon
Metabolic disease disrupts normal metabolism, resulting in altered systemic physiology. A challenge posed by metabolic diseases is that they are often present for years prior to becoming clinically apparent.
By Brad Swarbrick, CAMO Software
Welcome to Multivariate Data Analysis For Dummies, your guide to the rapidly growing area of data mining and predictive analytics. Multivariate analysis is set to change the mindset of many industries, and the way they approach the daunting task of analyzing large sets of data to extract the information they really need.
By Brad Larson, Peter Banks, Nicolas Pierre, and Grant Cameron
Three-dimensional (3D) cell culture is poised to meet the need for a more in vivo-like cellular model with which to test large and small molecules. This is accomplished by providing a method that allows for the reorganization of cells into a format which re-establishes the necessary cellular architecture and communication networks seen in normal tissue. Recently, a methodology has been put forth that incorporates a simplified procedure for the creation of a cell and collagen hydrogel mix. The inclusion of appropriate liquid handling instrumentations can further simplify the process, and ensure the generation of accurate, robust results.
By Jeff Clark, 7P Solutions™, LLC
The transportation and logistics world is accustomed to complying with regulations — from the Department of Transportation (DOT), to the International Air Transport Association (IATA), as well as country-specific import and export regulations. With the implementation of Good Distribution Practices (GDP) in the European Union, it is inevitable that the U.S. will follow suit, and the Food and Drug Administration (FDA) will adopt GDP as well. This is the foundation for securing the "identity, strength, quality, and purity" of all pharmaceutical products as defined in 21 CFR Part 211, Current Good Manufacturing Practices for Finished Pharmaceuticals (cGMP).